Mealey's (January 3, 2018, 10:23 AM EST) -- NEW YORK — Drug manufacturer Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay all 50 states and the District of Columbia $13.5 million to resolve allegations that it engaged in deceptive and misleading marketing of four drugs, the New York attorney general announced Dec. 20 (People of the State of New York, et al. v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 453287/2017, N.Y. Sup., New York Co.)....